Koppenhagen, FJBalemans, LTMSteerenberg, PAJagmont, TMden Otter, WStorm, G2025-03-172025-03-171999https://rivm.openrepository.com/handle/10029/638151The design of a pharmaceutically acceptable liposomal formulation of recombinant interleukin-2 (rIL-2) for locoregional anticancer immunotherapyArticleJ Liposome Res 1999; 9:313-292025-03-17